MSTC Share Price in Focus; Emerges as L1 Bidder for Coal India's 3-Year Auction Contract

MSTC Limited, a Government of India enterprise, disclosed under Regulation 30 of SEBI that it has been shortlisted as the L1 bidder for a tender issued by Coal India Limited to manage the linkage auction for the non regulated sector for a period of 3 years.
MSTC Named L1 Bidder for Coal India Tender
The tender, hosted on the GEM portal, seeks an external service provider to conduct the NRS linkage auction and to oversee execution of agreements through the MSTC platform. MSTC’s role will cover the full gamut of services from auction design to post‑auction contract finalisation.
Contract Scope and Duration
The agreement will remain valid for 3 years from the date of award. The services are domestic in nature and do not involve any related party transactions. No promoter or group interest exists in Coal India Limited.
Read More: SECL Identifies 7 Mine Dumps for Rare Earth Elements Extraction!
Consideration And Quantification
The precise financial consideration for the contract has not been quantified at this stage. The filing notes that the order size is pending final assessment.
Regulatory Disclosure Details
MSTC submitted the information to both the National Stock Exchange and BSE on 26 February, 2026, complying with SEBI Listing Obligations and Disclosure Requirements. The disclosure confirms that the award originates from a domestic entity and that the transaction is at arm’s length.
MSTC Share Price Performance
As of February 27, 2026, at 9:27 AM, MSTC share price on NSE was trading at ₹459.80 up by 1.75% from the previous closing price.
Conclusion
MSTC Limited’s selection as the L1 bidder positions it to deliver a 3‑year auction management service for Coal India Limited, expanding its portfolio of government‑linked service contracts.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Feb 27, 2026, 11:46 AM IST

Team Angel One
- Alembic Pharmaceuticals Share Price in Focus; US FDA Issues Form 483 With No Observations for Bioequivalence Unit in Gujarat
- Adani Ports Share Price in Focus; Receives SEBI Settlement Order Concerning Former Executives
- Glenmark Pharmaceuticals Share Price in Focus; Launches RYALTRIS Nasal Spray in Brazil
- Premier Energies Share Price in Focus; Unit Enters Binding Term Sheet for JV with RCT Energy India
- Mphasis Share Price in Focus; Partners with SGBS Unnati Foundation for Greener Bengaluru


